期刊文献+

联合检测慢性心力衰竭患者血清NT-proBNP、hs-CRP和cTnI的临床意义 被引量:18

Clinical significance of joint detection of serum NT-proBNP, hs-CRP and cTnI in chronic heart failure patients
下载PDF
导出
摘要 目的探讨血清氨基末端B型钠尿肽前体(NT-proBNP)、超敏C反应蛋白(hs-CRP)和心肌肌钙蛋白I(cTnI)的联合检测在慢性心力衰竭(CHF)诊断中的临床意义。方法将100例CHF患者按美国纽约心脏病协会(NYHA)分级方案分为Ⅰ、Ⅱ、Ⅲ、Ⅳ级,同时检测100例CHF患者和30例正常对照组NT-proBNP、hs-CRP和cTnI水平。结果 CHF患者不同心功能分级组间血清NT-proBNP、hsCRP和cTnI水平差异有统计学意义(P<0.05),并且随着心力衰竭严重程度的加重而增高;NYHAⅠ级患者的血清NT-proBNP、hs-CRP检测水平与对照组比较差异有统计学意义(P<0.05),cTnI检测水平差异无统计学意义(P>0.05)。结论 NT-proBNP是诊断CHF较好的心肌标志物,联合检测血清NT-proBNP、hs-CRP和cTnI水平可为慢性心力衰竭(CHF)提供诊断依据,且其升高幅度与病情的严重性相一致。 Objective To explore the clinical significance of joint detection of serum N-terminal pro- B-type natriuretic peptide (BNP), high sensitive C-reactive protein(hs-CRP) and cardiac troponin Ⅰ(cTnI) in the diagnosis of chronic heart failure(CHF). Methods According to the criteria of American New York Heart Association(NYHA), their heart functions of the 100 patients with CHF were classified into level Ⅰ-Ⅳ, and select the healthy control group 30 subjects. The levels of serm NT-proBNP, hs-CRP and cTnI were detected and analyzed in the CHF group and the control group. Results Compared with the control group, the levels of NT-proBNP, hs-CRP in CHF NYHA I grade group were significantly higher(P〈0.05), the level of cTnI was no significantly difference(P〉0.05); The levels of NT-proBNP, hs-CRP and cTnI bad statistical significance in different grades of CHF(P〈O.05); The NYHA class was worse, and the levels of three indicators were significantly higher. Conclusion NT-proBNP is a good cardiac marker for the diagnosis of CHF, joint detection of serum NT- proBNP, bs-CRP and cTnI levels provide reference supporty in the early diagnosis of CHF.
出处 《中国实用医药》 2014年第5期12-13,共2页 China Practical Medicine
关键词 氨基末端B型钠尿肽前体 超敏C反应蛋白 心肌肌钙蛋白I 慢性心力衰竭 N-terminal pro-B-type natriuretic peptide Cardiac Troponin I High sensitive C-reactiveprotein Chronic heart failure
  • 相关文献

参考文献5

二级参考文献22

共引文献206

同被引文献136

  • 1张鸿雁,刘同宝.心力衰竭患者血清C-反应蛋白变化及其临床意义[J].山东医药,2005,45(23):57-57. 被引量:5
  • 2张春玲,康金锁,陈曦,张丽,张健,杨跃进,丛祥凤.心血管病患者血浆N端B型脑钠肽水平变化及其临床意义[J].中华检验医学杂志,2006,29(1):31-34. 被引量:38
  • 3冯月娟,边双双,全龙娟,黄强,李旭.B型脑钠肽在慢性阻塞性肺病中的诊断价值[J].临床肺科杂志,2007,12(5):462-463. 被引量:21
  • 4Bo HM, Dong HN, Yong HK, et al. Coexpression of molecular chaperones to enhance functional expression of anti-BNP scFv in the cytoplasm of Eseherichia coli for the detection of B-type na- triuretic peptide[J]. World Journal of Microbiology & amp; Bio- technology,2011,27 (6) : 1391-1398.
  • 5Brady AJ,Poole Wilson PA. ESC-CHF: guidelines for the aspi- rational and the practical.[J]. Heart, 2006,92 (4) : 437-440.
  • 6Kavsak PA, Wang X, Ko DT, et al. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population,[J]. Clinical Chemistry, 2009,55 (10) : 1809-1815.
  • 7Cho SY, Kim Y, Cha SH, et al. Adjuvant laboratory marker of kawasaki disease; NT-pro-BNP or hs-CRP? [J]. Annals of Glinical and Laboratory Science,2011,41(4) :360-363.
  • 8Sahina T,Acara E,Celikyurtb U, et al. Relation of hs-CRP and BNP levels with the atrial spontaneous echo contrast and thrombi in permanent atrial fbrillation patients with different e- tiologies[J]. Medical science monitor, 2012,18(2):78-87.
  • 9Apple FS, Wu AH. Myocardial infarction redefined: role of cardiac troponin testing[ J ]. Clin Chem,2001 ,g7 ( 3 ) :377 - 389.
  • 10Tschope C, Kasner M, Westermann D, et al. The role of NT - proBNP in the diagnostics of isolated diastolic dyfunction : correlation with echocar - diographic and invasive measure- ments [ J ]. Eur Heart J,2005,26 (21) :2277 - 2284.

引证文献18

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部